Saturday, October 31, 2026

Beyond Meat Stock Went Down By Over 14% As Session Comes To An End On Tuesday

Beyond Meat Stock Went Down By Over 14% As Session Comes To An End On Tuesday

On Tuesday, shares of Beyond Meat, a major player in the plant-based meat market, fell by 14.53%. This downfall marked another in an unfavorable trading session for Beyond Meat alongside an overall dip of 1.12% seen across NASDAQ index stocks.

Beyond Meat's Stock Decline

Beyond Meat has seen its stock prices decline significantly from their 52-week high, indicating decreased investor trust or market attractiveness. Although the company's innovative food production methods and wide coverage include grocery stores, schools, and restaurants, Beyond Meat remains subject to challenging market conditions as evidenced by declining stock prices.

Earnings Per Share

Beyond Meat has generated an earnings per share (EPS) figure of 5.21 over its most recent twelve month earnings period - an indication of its profitability. This makes its stock price crash an opportunity for those willing to stake long-term bets on this company.

Fluctuating Sales Growth

A key issue facing the company is its negative sales growth for this quarter - down 26% year over year compared to its forecasted increase of 15.4% for next quarter. This difference could indicate uneven business performance or unexpected market trends that impact their company negatively.

Investor Caution and Company Adjustments

Given Beyond Meat's volatile stock value, investors are advised to exercise extreme care in their analysis and in keeping an eye on market trends and company performance. Furthermore, Beyond Meat must successfully adjust its sales trajectory if it wants to restore investor trust and stock performance.

More news about Beyond Meat (BYND).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com